Vanda Pharmaceuticals, Inc. (VNDA) Misses Q2 Expectations

July 31, 2013 6:57 AM

Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q2 EPS of ($0.26) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found